Skip to main content
SpringerLink
Log in

Role of Microdialysis in Pharmacokinetics and Pharmacodynamics: Current Status and Future Directions

  • Review Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Abstract

Diagnostic and therapeutic decisions in medical practice are still generally based on blood concentrations of drugs and/or biomolecules despite the knowledge that biochemical events and pharmacological effects usually take place in tissue rather than in the bloodstream. Microdialysis is a semi-invasive technique that is able to measure concentrations of the free, active drug or endogenous compounds in almost all human tissues and organs. It is currently being used to monitor brain metabolic processes and quantify tissue biomarkers, and determine transdermal drug distribution and tissue pharmacokinetics, confirming its importance as a widely used sampling technique in clinical drug monitoring and drug development as well as therapy and disease follow-up, contributing to rationalizing drug dosing regimens and influencing the clinical decision-making process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ungerstedt U, Pycock C. Functional correlates of dopamine neurotransmission. Bull Schweiz Akad Med Wiss. 1974;30:44–55.

    CAS  PubMed  Google Scholar 

  2. Plock N, Kloft C. Microdialysis—theoretical background and recent implementation in applied life-sciences. Eur J Pharm Sci. 2005;25:1–24.

    Article  CAS  Google Scholar 

  3. Muller M, De La Pena A, Derendorf H. Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue. Antimicrob Agents Chemother. 2004;48:1441–53.

    Article  Google Scholar 

  4. Johanssen MJ, Newman RA, Madden T. The use of microdialysis in pharmacokinetic and pharmacodynamic. Pharmacotherapy. 1997;17(3):464–81.

    Google Scholar 

  5. Chaurasia C, Müller M, Bashaw ED, et al. AAPS-FDA workshop white paper: microdialysis principles, application, and regulatory perspectives. J Clin Pharmacol. 2007;47:589–603.

    Article  CAS  Google Scholar 

  6. Ryan DM. Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans. Antimicrob Chemother. 1993;31 Suppl. D:1–16.

    Article  CAS  Google Scholar 

  7. Huse DM, Schulman K, Orsini L, et al. Burden of illness in Parkinson’s disease. Mov Disord. 2005;20:1449–54.

    Article  Google Scholar 

  8. Hillered L, Vespa PM, Hovda DA. Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis. J Neurotrauma. 2005;22(1):3–41.

    Article  Google Scholar 

  9. Brunner M, Derendorf H. Clinical microdialysis: current applications and potential use in drug development. Trends Anal Chem. 2006;25(7):674–80.

    Article  CAS  Google Scholar 

  10. Joukhadar C, Mueller M. Microdialysis: current applications in clinical pharmacokinetic studies and its potential role in the future. Clin Pharmacokinet. 2005;44(9):895–913.

    Article  CAS  Google Scholar 

  11. Carrel T, Schmid ER, von Segesser L, et al. Perioperative assessment of the likelihood of infection of the lower respiratory tract after cardiac surgery. Thorac Cardiovasc Surg. 1991;39:85–8.

    Article  CAS  Google Scholar 

  12. Brunner M, Pernersdorfer T, Mayer B, et al. Surgery and intensive care procedures affect the target site distribution of piperacillin. Crit Care Med. 2000;28:1754–9.

    Article  CAS  Google Scholar 

  13. Joukhadar C, Frossard M, Mayer BX, et al. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med. 2001;29:385–91.

    Article  CAS  Google Scholar 

  14. Hyatt JM, McKinnon PS, Zimmer GS, et al. The importance of pharmacokinetic/pharmacodynamics surrogate markers to outcome: focus on antibacterial agents. Clin Pharmacokinet. 1995;28:143–60.

    Article  CAS  Google Scholar 

  15. Theuretzbacher U. Tissue penetration of antibacterial agents: how should this be incorporated into pharmacodynamic analyses? Curr Opin Pharmacol. 2007;7:498–504.

    Article  CAS  Google Scholar 

  16. Mouton JW, Theuretzbacher U, Craig WA, et al. Tissue concentrations: do we ever learn? J Antimicrob Chemother. 2008;61:235–7.

    Article  CAS  Google Scholar 

  17. Traunmueller F, Zeitlinger M, Zeleny P, et al. Pharmacokinetics of single- and multiple-dose oral clarithromycin in soft tissues determined by microdialysis. Antmicrob Agents Chemother. 2007;519(9):3185–9.

    Article  Google Scholar 

  18. Hutschala D, Skhirtladze K, Kinstner C, et al. In vivo microdialysis to measure antibiotic penetration into soft tissue during cardiac surgery. Ann Thorac Surg. 2007;84:1605–10.

    Article  Google Scholar 

  19. Barbour A, Schmidt S, Rout RW, et al. Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery. Int J Antimicrob Agents. 2009;34:231–5.

    Article  CAS  Google Scholar 

  20. Hutschala D, Kinstner C, Skhirtladze K, et al. The impact of perioperative atelectasis on antibiotic penetration into lung tissue: an in vivo microdialysis study. J Intensive Care Med. 2008;34:1827–34.

    Article  CAS  Google Scholar 

  21. Poeppl W, Zeitlinger M, Donath O, et al. Penetration of doripenem in human brain: an observational microdialysis study in patients with acute brain injury. Int J Antimicrob Agents. 2012;39:343–5.

    Article  CAS  Google Scholar 

  22. Schmidt S, Barbour A, Sahre M, et al. PK/PD: new insights for antibacterial and antiviral applications. Curr Opin Pharmacol. 2008;8:549–56.

    Article  CAS  Google Scholar 

  23. Jain RK. Delivery of molecular medicine to solid tumors. Science. 1996;271(5252):1079–80.

    Article  CAS  Google Scholar 

  24. Zamboni WC, Houghton PJ, Hulstein JL, et al. Interpatient variability in bioavailability and pharmacokinetics of oral topotecan in children with relapsed solid tumors. Cancer Chemother Pharmacol. 1999;43:269–76.

    Article  CAS  Google Scholar 

  25. Brunner M, Muller M. Microdialysis: an in vivo approach for measuring drug delivery in oncology. Eur J Clin Pharmacol. 2002;58(4):227–34.

    Article  CAS  Google Scholar 

  26. Konings IR, Engels FK, Sleijfer S, et al. Application of prolonged microdialysis sampling in carboplatin-treated cancer patients. Cancer Chemother Pharmacol. 2009;64:509–16.

    Article  CAS  Google Scholar 

  27. Konings IR, Sleijfer S, Mathijssen RH, et al. Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study. Cancer Chemother Pharmacol. 2011;67(5):1055–62.

    Article  CAS  Google Scholar 

  28. Motl S, Zhuang Y, Waters CM, et al. Pharmacokinetic considerations in the treatment of CNS tumours. Clin Pharmacokinet. 2006;45:871–903.

    Article  CAS  Google Scholar 

  29. Cecchelli R, Berezowski V, Lundquist S, et al. Modelling of the blood-brain barrier in drug discovery, development. Nat Rev Drug Discov. 2007;6:650–61.

    Article  CAS  Google Scholar 

  30. Abbott N. Prediction of blood-brain barrier permeation in drug discovery from in vivo, in vitro, in silico models. Drug Discov Today Technol. 2004;1:407–16.

    Article  CAS  Google Scholar 

  31. Muldoon LL, Soussain C, Jahnke K, et al. Chemotherapy delivery issues in central nervous system malignancy: a reality check. J Clin Oncol. 2007;25:2295–305.

    Article  CAS  Google Scholar 

  32. Collins J, Dedrick R. Distributed model for drug delivery to CSF and brain tissue. Am J Physiol Regul Integr Comp Physiol. 1983;245(3):R303–10.

    Article  CAS  Google Scholar 

  33. de Lange E, Danhof M. Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain. Clin Pharmacokinet. 2002;41(10):691–703.

    Article  Google Scholar 

  34. Blakeley JO, Olson J, Grossman SA, et al. Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study. J Neurooncol. 2009;91:51–8.

    Article  CAS  Google Scholar 

  35. Portnow J, Badie B, Chen M, et al. The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implication for the current approach to chemoradiation. Clin Cancer Res. 2009;15:7092–8.

    Article  CAS  Google Scholar 

  36. Shah VP. Progress in methodologies for evaluating bioequivalence of topical formulations. Am J Clin Dermatol. 2001;2(5):275–80.

    Article  CAS  Google Scholar 

  37. Au WL, Skinner MF, Benfeldt E, et al. Application of dermal microdialysis for the determination of bioavailability of clobetasol propionate applied to the skin of human subjects. Skin Pharmacol Physiol. 2012;25:17–24.

    Article  CAS  Google Scholar 

  38. Ortiz PG, Hansen SH, Shah VP, et al. Are marketed topical metronidazole creams bioequivalent? Evaluation by in vivo microdialysis sampling and tape stripping methodology. Skin Pharmacol Physiol. 2011;24:44–53.

    Article  Google Scholar 

  39. Tettey-Amlalo RNO, Kanfer I, Skinner MF, et al. Application of dermal microdialysis for the evaluation of bioequivalence of a ketoprofen topical gel. Eur J Pharm Sci. 2009;36:219–25.

    Article  CAS  Google Scholar 

  40. Brunner M, Davies D, Martin W, et al. A new topical formulation enhances relative diclofenac bioavailability in healthy male subjects. Br J Clin Pharmacol. 2011;71(6):852–9.

    Article  CAS  Google Scholar 

  41. Simmel F, Kirbs C, Erdogan Z, et al. Pilot investigation on long-term subcutaneous microdialysis: proof of principle in humans. AAPS J. 2013;15(1):95–103.

    Article  CAS  Google Scholar 

  42. Ortiz PG, Hansen SH, Shah VP, et al. Impact of adult atopic dermatitis on topical drug penetration: assessment by cutaneous microdialysis and tape stripping. Acta Derm Venereol. 2009;89:33–8.

    Article  Google Scholar 

  43. Ortiz PG, Hansen SH, Shah VP, et al. The effect of irritant dermatitis on cutaneous bioavailability of a metronidazole formulation investigated by microdialysis and dermatopharmacokinetic methods. Cont Derm. 2008;59(1):23–30.

    Article  CAS  Google Scholar 

  44. Lonnroth P, Jansson PA, Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol. 1987;253(2 Pt 1):E228–31.

    CAS  PubMed  Google Scholar 

  45. Blin O, Audebert C, Pitel S, et al. Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies. Psychopharmacology. 2009;207:201–12.

    Article  CAS  Google Scholar 

  46. Olivecrona M, Rodling-Wahlstrom M, Naredi S, et al. Prostacyclin treatment in severe traumatic brain injury: a microdialysis and outcome study. J Neurotrauma. 2009;26:1251–62.

    Article  Google Scholar 

  47. Brody DL, Magnoni S, Schwetye KE, et al. Amyloid-β dynamics correlate with neurological status in the injured human brain. Science. 2008;321(5893):1221–4.

    Article  CAS  Google Scholar 

  48. Zsigmond P, Dernroth N, Kullman A, et al. Stereotactic microdialysis of the basal ganglia in Parkinson’s disease. J Neurosci Methods. 2012;207:17–22.

    Article  Google Scholar 

  49. Feichtner F, Schaller R, Fercher A, et al. Microdialysis based device for continuous extravascular monitoring of blood glucose. Biomed Microdevices. 2010;12:399–407.

    Article  CAS  Google Scholar 

  50. Rooyackers O, Blixt C, Mattsson P, Wernerman J. Continuous glucose monitoring by intravenous microdialysis. Acta Anaesthesiol Scand. 2010;54(7):841–7.

    Article  CAS  Google Scholar 

  51. Helmark IC, Mikkelsen UR, Børglum J, et al. Exercise increases interleukin-10 levels in both intraarticularly and peri-synovially in patients with knee osteoarthritis: a randomized controlled trial. Arth Res Ther. 2010;12:R126–37.

    Article  Google Scholar 

Download references

Acknowledgments

This manuscript was not supported by any grant. No founding sources were used in the preparation of this review and the authors have no conflicts of interest regarding the content of this review.

Author information

Authors and Affiliations

  1. Programa de Pós-Graduação em Ciências Farmacêuticas, UFRGS, Porto Alegre, Brazil

    Francine Johansson Azeredo & Teresa Dalla Costa

  2. Department of Pharmaceutics, College of Pharmacy, University of Florida, 1600 SW Archer Road, Gainesville, FL, 32610, USA

    Hartmut Derendorf

Authors
  1. Francine Johansson Azeredo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Teresa Dalla Costa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hartmut Derendorf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hartmut Derendorf.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Azeredo, F.J., Dalla Costa, T. & Derendorf, H. Role of Microdialysis in Pharmacokinetics and Pharmacodynamics: Current Status and Future Directions. Clin Pharmacokinet 53, 205–212 (2014). https://doi.org/10.1007/s40262-014-0131-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40262-014-0131-8

Keywords

Search

Navigation